PROFESSIONAL ADVISORY
Subscription
Your weekly science digest on longevity, mental health, and biotech.
Uma Path Insights
Stay ahead with curated updates from cutting-edge research. Every week we bring you the most relevant discoveries in longevity, mental health, and biotechnology - collected with AI and refined by our team of scientists.
GET A DEMO
What You Get
Weekly digest of key research papers, patents, and early clinical findings
Curated analysis from PhD scientists, MDs, and biotech experts
Actionable insights tailored for founders, investors, and strategists
Early visibility into trends in longevity, mental health, and biotech
First week free - cancel anytime
GET A DEMO
Why Uma Path Insights?
By the time science hits the media, it’s often too late to act - the investment round is already closed, the technology is locked, or competitors are scaling fast.
The real edge comes earlier: in freshly published research papers, patent filings, and preclinical data. But making sense of these signals requires deep scientific expertise. Few investors or founders can distinguish between noise and breakthrough.
That’s where Uma Path comes in. Our scientists - supported by AI - scan, analyse, and translate early science into clear, actionable insights.
With us, you see innovation before it becomes a headline.
Sample Issue (Preview)
Subscribe Today. First month free — cancel anytime
Biotech
Novel nanocarrier for targeted drug delivery published in Nature Nanotechnology. First preclinical data suggests broad oncology potential.
Longevity
New gene-editing approach extends median lifespan in murine models by 18%. Early IP filings suggest spinouts expected in 2026.
Mental Health
Breakthrough biomarker identified for treatment-resistant depression. Patent filed in July by a Cambridge-based startup.
Location
London, UK